Findings from Oriflame’s long-term R&D programme show Oripeptide-3 supporting five key biological drivers of ageing, reinforcing its central role in NovAge+ skin longevity formulations.
Tag: molecular skincare innovation oriflame
-
Skin biology advances as Oriflame presents new findings on Oripeptide-3 and ageing pathways
New scientific data from Oriflame has brought renewed attention to the biological science of skin longevity as the company revealed new findings on Oripeptide-3, its patented bioactivating technology. The research, released nationally on 25 November 2025, marks a significant step in Oriflame’s long-term exploration of skin ageing, cellular health and the dynamics that influence the skin’s functional lifespan. Over nearly twenty years of research and development, the company has examined how biological pathways govern ageing, and the latest findings provide evidence of how Oripeptide-3 interacts with five core drivers that shape the ageing process.
Oriflame’s research indicates that Oripeptide-3 plays a role in reactivating aged cells to improve overall function. This supports the view that cellular slowing, which occurs naturally with age, can be addressed by technologies designed to enhance biological communication and stimulate renewal. The company reports that Oripeptide-3 contributes to improved firmness and elasticity through its support of DNA protection. This is an area widely recognised in skin biology, where DNA integrity influences the skin’s ability to maintain structure and recover from damage. Protecting and supporting genetic stability helps the skin remain resilient against daily stressors, which over time influence visible signs of ageing.
Oriflame’s findings also indicate that Oripeptide-3 supports natural cellular renewal. Renewal cycles often slow down as skin matures, and this deceleration affects clarity, texture and vitality. The company’s research suggests that the technology helps stimulate natural renewal mechanisms, encouraging better turnover and improved skin tone. The support of cellular energy is another element noted in the new data. According to the company, maintaining adequate cellular energy is necessary for repair and daily defence, making it a crucial component of long-term skin health.
Edyta Kurek, Senior Vice President and Head of Oriflame India and Indonesia, added that consumers are increasingly seeking formulations that deliver long-term benefits backed by scientific evidence. Her remarks pointed to a wider consumer shift toward skincare that supports long-term health rather than quick results. She stated that innovations such as Oripeptide-3 demonstrate the company’s commitment to advanced research and future-ready formulations that align with the expectations of an informed and scientifically aware consumer base.
Oriflame continues to expand its portfolio based on its Swedish roots, focusing on nature-inspired innovation and an approach that integrates scientific research with an understanding of well-being. With a presence in more than sixty countries and a sales force of approximately three million independent brand partners, the company maintains a strong global footprint. Its operating principles reflect a clear focus on respect for people and the environment, and its social and environmental policies inform its approach to innovation, production and long-term brand development.